Article

Novel antibody cocktail therapy targeting extracellular tumor-specific mutations to treat triple-negative breast cancer

2025-03-10

Abstract excerpt

<title>Abstract</title> <p>Background Treatment options for triple-negative breast cancer (TNBC) remain limited, and the highly heterogeneous nature of these tumors often contributes to therapeutic resistance. While we have previously demonstrated that preparing a cocktail of antibodies targeting multiple distinct mutated cell surface proteins (MSPs) harboring neoepitopes unique to a given tumor can effectively...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9ba9fbf8-1ee0-5594-bb06-84beb61102c1
DOI: 10.21203/rs.3.rs-6073571/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Novel antibody cocktail therapy targeting extracellular tumor-specific mutations to treat triple-negative breast cancerDOI 10.21203/rs.3.rs-6073571/v1Read

Novel antibody cocktail therapy targeting extracellular tumor-specific mutations to treat EMT6 cell line-derived triple-negative breast cancer.Semantic proximity Read

Emerging Protein Targets in Triple Negative Breast Cancer: Beyond Conventional TherapySemantic proximity Read

Advances in immunotherapy for triple-negative breast cancerSemantic proximity Read

Modeling Heterogeneity of Triple‐Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug ResistanceSemantic proximity Read

Modeling Heterogeneity of Triple-Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug ResistanceSemantic proximity Read

Cancer therapy via neoepitope-specific monoclonal antibody cocktailsSemantic proximity Read

Murine models for triple-negative breast cancer with differential responsiveness to immunotherapySemantic proximity Read

Development of T-cell engagers selective for cells co-expressing two antigensSemantic proximity Read

EGFR as a potent CAR T target in Triple Negative Breast Cancer Brain MetastasesSemantic proximity Read

Triepitopic antibody fusions inhibit cetuximab-resistant BRAF and KRAS mutant tumors via EGFR signal repression.Semantic proximity Read

Targeted Therapies for Triple-Negative Breast Cancer.Semantic proximity Read

A cocktail of antibodies to multiple tumor-specific neoantigens increases binding and inhibits tumor growthSemantic proximity Read